The Global Epigenetics Market is on an accelerated growth trajectory, driven by cutting‑edge advancements in molecular diagnostics, personalized medicine, and cancer research. According to The Insight Partners, the market is forecast to expand from US$ 11.12 billion in 2024 to an estimated US$ 35.84 billion by 2031, registering a robust CAGR of 18.3% during the 2025‑2031 period. This surge is...

"Executive Summary Epigenetics-Based Therapeutics Market Research: Share and Size Intelligence CAGR Value The global epigenetics-based therapeutics market size was valued at USD 1.76 billion in 2024 and is expected to reach USD 5.17 billion by 2032, at a CAGR of 14.40% during the forecast period The all-inclusive Epigenetics-Based Therapeutics...